Personlig patologi och cancerbehandling

Forskningsoutput

Forskningsoutput per år 2009 2017 2018 2019 2022

• 66 Artikel i vetenskaplig tidskrift
• 13 Doktorsavhandling (sammanläggning)
• 1 Konferensabstract
• 1 Poster
• 1 Mer
  • 1 Publicerat konferensabstract

Forskningsoutput per år

Forskningsoutput per år

Sökresultat

• 2022

  Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer

  Loughman, T., Barron, S., Wang, C-J. A., Dynoodt, P., Fender, B., Lopez-Ruiz, C., Stapleton, S., Fabre, A., Quinn, C., Nodin, B., Jirström, K., Razmara, F., O’Grady, A., Baird, A-M., Gray, S. G., Freixo, A., Moelans, C. B., van Diest, P. J., Duffy, M. J., O’Leary, D., & 3 andraCrown, J., Bracken, A. P. & Gallagher, W. M., 2022 juni 1, I: Clinical Chemistry. 68, 6, s. 837-847

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Estrogen Receptors 100%
  • RNA 74%
  • Breast Neoplasms 68%
  • Recurrence 61%
  • Formaldehyde 59%

• A Prospective Diet-Wide Association Study for Risk of Colorectal Cancer in EPIC

  Papadimitriou, N., Bouras, E., van den Brandt, P. A., Muller, D. C., Papadopoulou, A., Heath, A. K., Critselis, E., Gunter, M. J., Vineis, P., Ferrari, P., Weiderpass, E., Boeing, H., Bastide, N., Merritt, M. A., Lopez, D. S., Bergmann, M. M., Perez-Cornago, A., Schulze, M., Skeie, G., Srour, B., & 29 andraEriksen, A. K., Boden, S., Johansson, I., Nøst, T. H., Lukic, M., Ricceri, F., Ericson, U., Huerta, J. M., Dahm, C. C., Agnoli, C., Amiano, P. E., Tjønneland, A., Gurrea, A. B., Bueno-de-Mesquita, B., Ardanaz, E., Berntsson, J., Sánchez, M. J., Tumino, R., Panico, S., Katzke, V., Jakszyn, P., Masala, G., Derksen, J. W. G., Quirós, J. R., Severi, G., Cross, A. J., Riboli, E., Tzoulaki, I. & Tsilidis, K. K., 2022, I: Clinical Gastroenterology and Hepatology. 20, 4, s. 864-873.e13

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Colorectal Neoplasms 100%
  • Diet 86%
  • Confidence Intervals 75%
  • Neoplasms 40%
  • Riboflavin 36%

• Expression of cartilage oligomeric matrix protein in periampullary adenocarcinoma is associated with pancreatobiliary-type morphology, higher levels of fibrosis and immune cell exclusion

  Papadakos, K. S., Lundgren, S., Gialeli, C., Micke, P., Mezheyeuski, A., Elebro, J., Jirström, K. & Blom, A. M., 2022, I: OncoImmunology. 11, 1, 2111906.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Cartilage Oligomeric Matrix Protein 100%
  • Adenocarcinoma 51%
  • Fibrosis 48%
  • Neoplasms 21%
  • Fast Green 11%

• High infiltration of CD68+/CD163- macrophages is an adverse prognostic factor after neoadjuvant chemotherapy in esophageal and gastric adenocarcinoma

  Svensson, M. C., Svensson, M., Nodin, B., Borg, D., Hedner, C., Hjalmarsson, C., Leandersson, K. & Jirström, K., 2022, I: Journal of Innate Immunity. 14, 6 , s. 615-628

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Adenocarcinoma 100%
  • Stomach 91%
  • Macrophages 89%
  • Drug Therapy 75%
  • Neoplasms 41%

• Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer

  Godina, C., Indira Chandran, V., Barbachowska, M., Tryggvadottir, H., Nodin, B., Visse, E., Borgquist, S., Jirström, K., Isaksson, K., Bosch, A., Belting, M. & Jernström, H., 2022 aug., I: Translational Oncology. 22, 101464.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Caveolin 1 100%
  • Body Size 89%
  • Breast Neoplasms 49%
  • Neoplasms 24%
  • Recurrence 16%
• 2021

  Development and validation of a lifestyle-based model for colorectal cancer risk prediction: the LiFeCRC score

  Aleksandrova, K., Reichmann, R., Kaaks, R., Jenab, M., Bueno-de-Mesquita, H. B., Dahm, C. C., Eriksen, A. K., Tjønneland, A., Artaud, F., Boutron-Ruault, M. C., Severi, G., Hüsing, A., Trichopoulou, A., Karakatsani, A., Peppa, E., Panico, S., Masala, G., Grioni, S., Sacerdote, C., Tumino, R., & 22 andraElias, S. G., May, A. M., Borch, K. B., Sandanger, T. M., Skeie, G., Sánchez, M. J., Huerta, J. M., Sala, N., Gurrea, A. B., Quirós, J. R., Amiano, P., Berntsson, J., Drake, I., van Guelpen, B., Harlid, S., Key, T., Weiderpass, E., Aglago, E. K., Cross, A. J., Tsilidis, K. K., Riboli, E. & Gunter, M. J., 2021, I: BMC Medicine. 19, 1, 1.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Life Style 100%
  • Colorectal Neoplasms 97%
  • Vegetable Products 24%
  • Dairy Products 19%
  • Nomograms 18%

• INFORM: INFrared-based ORganizational Measurements of tumor and its microenvironment to predict patient survival

  Tiwari, S., Kajdacsy-Balla, A., Whiteley, J., Cheng, G., Jirström, K., Birgisson, H., Hewitt, S. M. & Bhargava, R., 2021 feb. 3, I: Science Advances. 7, 6, s. 1-10

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Tumor Microenvironment 100%
  • Survival 53%
  • Neoplasms 31%
  • Colonic Neoplasms 21%
  • Disease Progression 19%

• Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer: A prospective cohort study

  Godina, C., Khazaei, S., Tryggvadottir, H., Visse, E., Nodin, B., Jirström, K., Borgquist, S., Bosch, A., Isaksson, K. & Jernström, H., 2021 nov. 1, I: Carcinogenesis. 42, 11, s. 1314-1325 12 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • insulin-like growth factor binding protein-related protein 1 100%
  • Cohort Studies 40%
  • Breast Neoplasms 37%
  • Prospective Studies 37%
  • Neoplasms 18%
• 2019

  Clinical impact of T cells, B cells and the PD-1/PD-L1 pathway in muscle invasive bladder cancer: a comparative study of transurethral resection and cystectomy specimens

  Wahlin, S., Nodin, B., Leandersson, K., Boman, K. & Jirström, K., 2019, I: OncoImmunology. 8, 11, e1644108.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • B-Lymphocyte Subsets 100%
  • Cystectomy 89%
  • Urinary Bladder Neoplasms 76%
  • T-Lymphocytes 49%
  • Muscles 47%

• Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma

  Andersson, G., Lundgren, S., Heby, M., Nodin, B., Elebro, J. & Jirström, K., 2019 nov. 19, I: Biomarker research. 7, 1, 26.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Estrogen 100%
  • Progesterone Receptors 98%
  • Estrogen Receptors 87%
  • Adenocarcinoma 73%
  • Neoplasms 30%

• Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

  Lundgren, S., Fagerström-Vahman, H., Zhang, C., Ben-Dror, L., Mardinoglu, A., Uhlen, M., Nodin, B. & Jirström, K., 2019 jan. 14, I: Biomarker research. 7, 1, 1.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Biological Marker 100%
  • Melanoma 92%
  • Carcinogenesis 84%
  • Biomarkers 72%
  • Health 54%

• Expression of PD-L1 and PD-1 in chemoradiotherapy-Naïve esophageal and gastric adenocarcinoma: Relationship with mismatch repair status and survival

  Svensson, M. C., Borg, D., Zhang, C., Hedner, C., Nodin, B., Uhlén, M., Mardinoglu, A., Leandersson, K. & Jirström, K., 2019 mars 13, I: Frontiers in Oncology. 9, MAR, 136.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Death Domain Receptors 100%
  • DNA Mismatch Repair 96%
  • Chemoradiotherapy 86%
  • Adenocarcinoma 63%
  • Stomach 58%

• Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study

  Murphy, N., Jirström, K., Berntsson, J. & et al., 2019, I: Clinical Gastroenterology and Hepatology. 17, 7, s. 1323-1331

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Colonic Neoplasms 100%
  • Colorectal Neoplasms 87%
  • Cohort Studies 75%
  • Rectal Neoplasms 67%
  • Colon 53%

• Immune effector monocyte–neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer

  Hagerling, C., Gonzalez, H., Salari, K., Wang, C. Y., Lin, C., Robles, I., van Gogh, M., Dejmek, A., Jirström, K. & Werb, Z., 2019, I: Proceedings of the National Academy of Sciences of the United States of America. 116, 43, s. 21704-21714 11 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Monocytes 100%
  • Neutrophils 94%
  • Breast Neoplasms 76%
  • Lung 43%
  • Neoplasms 38%

• Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases

  Vidarsdottir, H., Tran, L., Nodin, B., Jirström, K., Planck, M., Jönsson, P., Mattsson, J. S. M., Botling, J., Micke, P. & Brunnström, H., 2019, I: Human Pathology. 84, s. 221-230 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Lung Neoplasms 100%
  • Neoplasm Metastasis 78%
  • Lung 67%
  • Adenocarcinoma of Lung 45%
  • Renal Cell Carcinoma 20%

• Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer

  Micke, P., Botling, J., Mattsson, J. S. M., Planck, M., Tran, L., Vidarsdottir, H., Nodin, B., Jirström, K. & Brunnström, H., 2019 dec. 1, I: Scientific Reports. 9, 1, 1319.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Thyroid Nuclear Factor 1 100%
  • Mucins 91%
  • Periodic Acid 84%
  • Non-Small Cell Lung Carcinoma 75%
  • Amylases 74%

• Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome

  Lundgren, S., Olsson Hau, S., Elebro, J., Heby, M., Karnevi, E., Nodin, B., Eberhard, J., Holm, K., Staaf, J., Jönsson, G. B. & Jirström, K., 2019 mars 21, I: JCO Precision Oncology. 3, s. 1-8

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Adenocarcinoma 100%
  • Mutation 42%
  • Neoplasms 41%
  • Adjuvant Chemotherapy 25%
  • High-Throughput Nucleotide Sequencing 12%

• Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition

  Berntsson, J., Eberhard, J., Nodin, B., Leandersson, K., Larsson, A. H. & Jirström, K., 2019 nov. 5, I: OncoImmunology. 8, 12, 9 s., e1664275.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Anthropometry 100%
  • Colorectal Neoplasms 66%
  • Obesity 48%
  • Waist-Hip Ratio 32%
  • Body Mass Index 29%
  78 Nedladdningar (Pure)

• Prognostic Impact of Tumor Cell Programmed Death Ligand 1 Expression and Immune Cell Infiltration in NSCLC

  Edlund, K., Madjar, K., Mattsson, J. S. M., Djureinovic, D., Lindskog, C., Brunnström, H., Koyi, H., Brandén, E., Jirström, K., Pontén, F., Rahnenführer, J., Micke, P. & Hengstler, J. G., 2019, I: Journal of Thoracic Oncology. 14, 4, s. 628-640

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Ligands 100%
  • Apoptosis 86%
  • Lymphocytes 83%
  • Survival 67%
  • Neoplasms 45%

• Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition

  Costas, L., Lujan-Barroso, L., Benavente, Y., Allen, N. E., Amiano, P., Ardanaz, E., Besson, C., Boeing, H., Bueno-de-Mesquita, B., Cervenka, I., Fortner, R. T., Fournier, A., Gunter, M., Harlid, S., Huerta, J. M., Jerkeman, M., Jirström, K., Kaaks, R., Karakatsani, A., Khaw, K. T., & 22 andraKotanidou, A., Lund, E., Masala, G., Mattiello, A., Melin, B., Menéndez, V., Murphy, N., Nieters, A., Overvad, K., Riboli, E., Sacerdote, C., Sánchez, M. J., Schmidt, J. A., Sieri, S., Tjønneland, A., Trichopoulou, A., Tumino, R., Vermeulen, R., Weiderpass, E., de Sanjosé, S., Agudo, A. & Casabonne, D., 2019, I: American Journal of Epidemiology. 188, 2, s. 274-281 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • B-Cell Lymphoma 100%
  • Non-Hodgkin's Lymphoma 91%
  • Hormones 68%
  • Menopause 66%
  • Birth Order 39%
• 2018

  Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer

  Loughman, T., Chan-Ju Wang, A., Dynoodt, P., Fender, B., Lopez Ruiz, C., Barron, S., Stapleton, S., O'Leary, D., Fabre, A., Quinn, C., Nodin, B., Jirstrom, K., Bracken, A. & Gallagher, W. M., 2018, I: Annals of oncology : official journal of the European Society for Medical Oncology. 29, Suppl. 8, s. viii65

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Hormones 100%
  • Breast Neoplasms 90%
  • Recurrence 81%
  • RNA 49%
  • Polymerase Chain Reaction 41%

• A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer

  Wendel, U., Persson, N., Risinger, C., Bengtsson, E., Nodin, B., Danielsson, L., Welinder, C., Fredrikson, G. N., Jansson, B. & Blixt, O., 2018 feb. 1, I: PLoS ONE. 13, 2, e0191872.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • N(6)-carboxymethyllysine 100%
  • Advanced Glycation End Products 79%
  • Pancreatic Neoplasms 62%
  • Atherosclerosis 53%
  • Monoclonal Antibodies 48%

• Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases

  Vidarsdottir, H., Tran, L., Nodin, B., Jirström, K., Planck, M., Mattsson, J. S. M., Botling, J., Micke, P., Jönsson, P. & Brunnström, H., 2018, I: American Journal of Clinical Pathology. 150, 6, s. 533-544 12 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Thyroid Nuclear Factor 1 100%
  • Clone Cells 53%
  • Lung Neoplasms 53%
  • Neoplasm Metastasis 41%
  • Lung 36%

• Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma

  Lundgren, S., Fagerström-Vahman, H., Ben-Dror, L., Nodin, B. & Jirstrom, K., 2018, I: Annals of oncology : official journal of the European Society for Medical Oncology. 29, Suppl. 8, s. viii463

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Melanoma 100%
  • Biomarkers 78%
  • Atlases 38%
  • Neoplasms 34%
  • Recurrence 20%

• Hormonal factors and pancreatic cancer risk in women: The Malmö Diet and Cancer Study

  Andersson, G., Borgquist, S. & Jirström, K., 2018 juli 1, I: International Journal of Cancer. 143, 1, s. 52-62 11 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Pancreatic Neoplasms 100%
  • Diet 72%
  • Confidence Intervals 47%
  • Neoplasms 34%
  • Hormone Replacement Therapy 29%

• Interactions between ABCB1genotype and preoperative statin use impact clinical outcomes among breast cancer patients

  Tryggvadottir, H., Huzell, L., Gustbée, E., Simonsson, M., Markkula, A., Jirström, K., Rose, C., Ingvar, C., Borgquist, S. & Jernström, H., 2018 okt. 12, I: Frontiers in Oncology. 8, OCT

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 100%
  • Breast Neoplasms 65%
  • Genotype 53%
  • Oxidoreductases 25%
  • Coenzyme A 23%

• Intratumoural leukocyte infiltration is a prognostic indicator among pancreatic cancer patients with type 2 diabetes

  Karnevi, E., Sasor, A., Hilmersson, K. S., Ansari, D., Erjefält, J. S., Rosendahl, A. H. & Andersson, R., 2018, I: Pancreatology. 18, 1, s. 85-93

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Pancreatic Neoplasms 100%
  • Leukocytes 83%
  • Type 2 Diabetes Mellitus 79%
  • Macrophages 29%
  • Neoplasms 20%

• MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer

  Stene, C., Polistena, A., Gaber, A., Nodin, B., Ottochian, B., Adawi, D., Avenia, N., Jirström, K. & Johnson, L. B., 2018 jan. 1, I: In Vivo. 32, 1, s. 133-138 6 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Rectal 100%
  • Matrix Metalloproteinase 7 97%
  • Rectal Neoplasms 69%
  • Radiotherapy 46%
  • Transforming Growth Factor beta 25%

• Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma

  Borg, D., Larsson, A. H., Hedner, C., Nodin, B., Johnsson, A. & Jirström, K., 2018, I: Journal of Translational Medicine. 16, 1, 290.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • podocalyxin 100%
  • Biological Marker 55%
  • Adenocarcinoma 47%
  • Stomach 43%
  • Biomarkers 39%

• Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor-infiltrating immune cell composition

  Berntsson, J., Eberhard, J., Nodin, B., Larsson, A. H. & Jirstrom, K., 2018, I: Annals of oncology : official journal of the European Society for Medical Oncology. 29, Suppl. 8, s. viii180

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anthropometry 100%
  • Colorectal Neoplasms 66%
  • Neoplasms 26%
  • Obesity 26%
  • Body Mass Index 21%

• Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma

  Siesing, C., Svensson, M. C., Hedner, C., Nodin, B., Borg, D. & Jirstrom, K., 2018, I: Annals of oncology : official journal of the European Society for Medical Oncology. 29, Suppl. 8, s. viii220

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Chemoradiotherapy 100%
  • Lymphocyte Activation 99%
  • Adenocarcinoma 73%
  • Stomach 67%
  • Gene Expression 56%

• Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

  Kaaks, R., Fortner, R. T., Hüsing, A., Barrdahl, M., Hopper, M., Johnson, T., Tjønneland, A., Hansen, L., Overvad, K., Fournier, A., Boutron-Ruault, M. C., Kvaskoff, M., Dossus, L., Johansson, M., Boeing, H., Trichopoulou, A., Benetou, V., La Vecchia, C., Sieri, S., Mattiello, A., & 22 andraPalli, D., Tumino, R., Matullo, G., Onland-Moret, N. C., Gram, I. T., Weiderpass, E., Sánchez, M. J., Navarro Sanchez, C., Duell, E. J., Ardanaz, E., Larranaga, N., Lundin, E., Idahl, A., Jirström, K., Nodin, B., Travis, R. C., Riboli, E., Merritt, M., Aune, D., Terry, K., Cramer, D. W. & Anderson, K. S., 2018, I: International Journal of Cancer. 143, 3, s. 515-526

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Autoantibodies 100%
  • Ovarian Neoplasms 98%
  • Neoplasms 34%
  • Ovarian Epithelial Carcinoma 31%
  • Testicular Neoplasms 30%

• Tumor characteristics and prognosis in women with pregnancy-associated breast cancer

  Johansson, A. L. V., Andersson, T. M. L., Hsieh, C. C., Jirström, K., Cnattingius, S., Fredriksson, I., Dickman, P. W. & Lambe, M., 2018, I: International Journal of Cancer. 142, 7, s. 1343-1354

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Breast Neoplasms 100%
  • Pregnancy 94%
  • Neoplasms 50%
  • Age Distribution 13%
  • Parturition 8%
• 2017

  Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups

  Niméus, E., Folkesson, E., Nodin, B., Hartman, L. & Klintman, M., 2017 dec. 1, I: Anticancer research. 37, 12, s. 6845-6853 9 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Androgen Receptors 100%
  • Breast Neoplasms 59%
  • Tamoxifen 9%
  • Cytoplasmic and Nuclear Receptors 9%
  • Survival Analysis 9%

• Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer

  Topi, G., Ehrnström, R., Jirström, K., Palmquist, I., Lydrup, M. L. & Sjölander, A., 2017 sep. 1, I: European Journal of Cancer. 83, s. 279-289 11 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Estrogen Receptor beta 100%
  • Colorectal Neoplasms 62%
  • Hormones 55%
  • Life Style 50%
  • Confidence Intervals 27%

• Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer

  Ghanipour, L., Jirström, K., Sundström, M., Glimelius, B. & Birgisson, H., 2017 feb. 1, I: European Journal of Surgical Oncology. 43, 2, s. 311-321

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Heredity 100%
  • DNA Mismatch Repair 91%
  • Colorectal Neoplasms 61%
  • Colonic Neoplasms 39%
  • Genes 30%

• Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer

  Björner, S., Rosendahl, A. H., Simonsson, M., Markkula, A., Jirström, K., Borgquist, S., Rose, C., Ingvar, C. & Jernström, H., 2017 nov. 28, I: Frontiers in Endocrinology. 8, NOV, 332.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Insulin Receptor 100%
  • Cytoplasmic and Nuclear Receptors 90%
  • Estrogen Receptors 82%
  • Body Mass Index 63%
  • Breast Neoplasms 56%

• Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer

  Lindquist, K. E., Karlsson, A., Levéen, P., Brunnström, H., Reuterswärd, C., Holm, K., Jönsson, M., Annersten, K., Rosengren, F., Jirström, K., Kosieradzki, J., Ek, L., Borg, Å., Planck, M., Jönsson, G. & Staaf, J., 2017 maj 23, I: Oncotarget. 8, 21, s. 34796-34810 15 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Gene Fusion 100%
  • High-Throughput Nucleotide Sequencing 84%
  • Non-Small Cell Lung Carcinoma 79%
  • Mutation 49%
  • Squamous Cell Carcinoma 36%

• Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition

  Caini, S., Masala, G., Saieva, C., Kvaskoff, M., Savoye, I., Sacerdote, C., Hemmingsson, O., Hammer Bech, B., Overvad, K., Tjønneland, A., Petersen, K. E. N., Mancini, F. R., Boutron-Ruault, M-C., Cervenka, I., Kaaks, R., Kühn, T., Boeing, H., Floegel, A., Trichopoulou, A., Valanou, E., & 28 andraKritikou, M., Tagliabue, G., Panico, S., Tumino, R., Bueno-De-Mesquita, B. H., Peeters, P. H., Veierød, M. B., Ghiasvand, R., Lukic, M., Quirós, J. R., Chirlaque, M. D., Ardanaz, E., Salamanca Fernández, E., Larrañaga, N., Zamora-Ros, R., Maria Nilsson, L., Ljuslinder, I., Jirström, K., Sonestedt, E., Key, T. J., Wareham, N., Khaw, K. T., Gunter, M., Huybrechts, I., Murphy, N., Tsilidis, K. K., Weiderpass, E. & Palli, D., 2017 maj 15, I: International Journal of Cancer. 140, 10, s. 2246-2255 10 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Coffee 100%
  • Tea 92%
  • Melanoma 69%
  • Neoplasms 27%
  • Confidence Intervals 18%

• High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort

  Elebro, K., Borgquist, S., Rosendahl, A. H., Markkula, A., Simonsson, M., Jirström, K., Rose, C., Ingvar, C. & Jernström, H., 2017, I: Clinical Cancer Research. 23, 3, s. 766-777

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Adjuvant Chemotherapy 100%
  • Estrogen Receptors 92%
  • Breast Neoplasms 62%
  • Protein Isoforms 47%
  • Population 38%

• High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

  Siesing, C., Sorbye, H., Dragomir, A., Pfeiffer, P., Qvortrup, C., Pontén, F., Jirström, K., Glimelius, B. & Eberhard, J., 2017, I: PLoS ONE. 12, 8, e0182512.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • RNA-Binding Motifs 100%
  • Oxaliplatin 84%
  • RNA-Binding Proteins 82%
  • Colorectal Neoplasms 56%
  • Survival 39%

• Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer

  Allaoui, R., Hagerling, C., Desmond, E., Warfvinge, C. F., Jirström, K. & Leandersson, K., 2017, I: Cancer Biomarkers. 20, 4, s. 395-409 15 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Interleukin-17 100%
  • Breast Neoplasms 60%
  • T-Lymphocytes 58%
  • Tumor-Infiltrating Lymphocytes 10%
  • Cytotoxic T-Lymphocytes 9%

• Podocalyxin-like and rna-binding motif protein 3 are prognostic biomarkers in urothelial bladder cancer: A validatory study

  Boman, K., Andersson, G., Wennersten, C., Nodin, B., Ahlgren, G. & Jirström, K., 2017 mars 14, I: Biomarker research. 5, 1, s. 1-10 10.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • podocalyxin 100%
  • RNA-Binding Motifs 85%
  • RNA-Binding Proteins 70%
  • Urinary Bladder Neoplasms 58%
  • Biological Marker 55%

• Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters

  Grinberg, M., Djureinovic, D., Brunnström, H. RR., Mattsson, J. S., Edlund, K., Hengstler, J. G., La Fleur, L., Ekman, S., Koyi, H., Branden, E., Ståhle, E., Jirström, K., Tracy, D. K., Pontén, F., Botling, J., Rahnenführer, J. & Micke, P., 2017 juli, I: Modern Pathology. 30, 7, s. 964-977 14 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Tumor Biomarkers 100%
  • Non-Small Cell Lung Carcinoma 91%
  • Biomarkers 44%
  • Proteins 37%
  • Immunohistochemistry 23%

• The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype

  Lundgren, S., Karnevi, E., Elebro, J., Nodin, B., Karlsson, M. C. I., Eberhard, J., Leandersson, K. & Jirström, K., 2017 juli 3, I: Journal of Translational Medicine. 15, 1, 152.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Adjuvant 100%
  • Dendritic Cells 72%
  • Adenocarcinoma 63%
  • Macrophages 56%
  • Biological Marker 36%

• The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size

  Simonsson, M., Björner, S., Markkula, A., Nodin, B., Jirström, K., Rose, C., Borgquist, S., Ingvar, C. & Jernström, H., 2017 jan., I: International Journal of Cancer. 140, 1, s. 163-175

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Reproductive History 100%
  • Oral Contraceptives 86%
  • Cyclooxygenase 2 84%
  • Anti-Inflammatory Agents 59%
  • Interviews 53%
  175 Nedladdningar (Pure)
• 2016

  Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

  Escudero-Esparza, A., Bartoschek, M., Gialeli, C., Okroj, M., Owen, S., Jirström, K., Orimo, A., Jiang, W. G., Pietras, K. & Blom, A. M., 2016, I: Oncotarget. 7, 47, s. 76920-76933 14 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Complement Inactivating Agents 100%
  • Breast Neoplasms 43%
  • Tumor Suppressor Genes 40%
  • Neoplasms 22%
  • Aldehyde Dehydrogenase 17%

• Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma

  Elebro, J., Heby, M., Warfvinge, C. F., Nodin, B., Eberhard, J. & Jirström, K., 2016 apr. 12, I: PLoS ONE. 11, 4, e0153533.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • human ERBB2 protein 100%
  • Adenocarcinoma 63%
  • Survival 36%
  • Neoplasms 26%
  • Gene Amplification 19%

• Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study

  Andersson, G., Wennersten, C., Borgquist, S. & Jirström, K., 2016 dec. 9, I: Biology of Sex Differences. 7, 1, 66.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Sex Factors 100%
  • Anthropometry 91%
  • Pancreatic Neoplasms 72%
  • cancer 69%
  • diagnostic 64%

• Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer

  Berntsson, J., Nodin, B., Eberhard, J., Micke, P. & Jirström, K., 2016 sep. 1, I: International Journal of Cancer. 139, 5, s. 1129-39 11 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Plasma Cells 100%
  • Immunoglobulins 88%
  • Colorectal Neoplasms 79%
  • B-Lymphocytes 76%
  • Regression Analysis 32%